Document is current
Any future updates will be listed below
-
Authors
Nikesjö, Frida
Sayyab, Shumaila
Karlsson, Lovisa
Apostolou, Eirini
Rosén, Anders
Hedman, Kristofer
Lerm, Maria
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (4.3-2019-00201 GD-2020-138, 2021-03183)
Swedish Heart and Lung Foundation (20210067)
Linköping University
- License Information
-
More Information
Article History
Received: 1 July 2022
Accepted: 5 December 2022
First Online: 14 December 2022
Declarations
:
: The study was approved in April 2021 by Swedish Ethical Review Authority (Dnr. 2021‐01620) (KH). The studies involving CC19 and Con participants were reviewed and approved by the Swedish Ethical Review Authority, Regional Ethics Committee (Dnr. 2019-0618) (AR). The participants provided their written informed consent to participate in this study.
: Not applicable.
: ML and SS have filed a patent “Method for determining SARS-CoV-2 exposure with or without remaining symptoms” (WO2022119495A1). None of the remaining authors declare any competing interests.
